Mon4strat
Therapeutic bedside monitoring of beta-lactam antibiotics in neonates with suspected or proven late onset sepsis: observational study
- Observational study in neonates and infants, Infants with chronological age < 90 days old with confirmed or suspected sepsis requiring treatment with study antibiotics (piperacillin/tazobactam, ceftazidime, cefepime or meropenem) will be included.
- Study objective is to assess the ability to perform real-time monitoring of beta-lactam antibioticswith the MON4STRAT device in neonates and infants.
Link
EUDRA-CT
2018-000450-21
Funding
European Commission, under the FP7 programme
Partners
- Université de Liège, Belgium;
- Université catholique de Louvain, Belgium;
- WOW Industries, Belgium;
- Institute of Cardiometabolism and Nutrition. France;
- Servicio Madrileño de la Salud. Spain;
- University of Houston, USA;
- Université libre de Bruxelles , Belgium;
- Université Lille Nord de France CHRU-Lille, France;
- EXPRIMO, Belgium;
- AEPODIA, Belgium,
- University of Tartu, Estonia
